Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2003
10/02/2003US20030187071 Process and intermediates to prepare latanoprost
10/02/2003US20030187060 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
10/02/2003US20030187053 Eating disorders; antilipemic agents; anticholesterol agents; cardiovascular disorders
10/02/2003US20030187041 Cardiovascular disorders
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/02/2003US20030186962 Cysteine protease inhibitors
10/02/2003US20030186944 Novel aromatic compounds
10/02/2003US20030186924 Prodrugs
10/02/2003US20030186395 Chemo-enzymatic synthesis of optically enriched rose-oxides
10/02/2003CA2780743A1 Substituted tetracycline compounds
10/01/2003EP1347968A1 Lfa-1 antagonist compounds
10/01/2003EP1347963A2 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors
10/01/2003EP1347950A1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
10/01/2003CN1446089A Pharmaceutical composition containing citalopram
10/01/2003CN1445221A Pharmaceutical application of derivant of benzofuran-ketone
10/01/2003CN1445220A Lactone category compound of sweetsop as well as new usage in medicines and its preparing method
09/2003
09/30/2003US6627767 Controlling cellular metabolism
09/30/2003US6627652 Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003078416A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003WO2003078415A1 Cyclic hemiacetal derivative and use thereof
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003WO2003078310A2 Method for the production of a catalyst containing vanadium, phosphorus, and oxygen
09/25/2003WO2003078059A1 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
09/25/2003WO2003078058A1 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
09/25/2003WO2003077653A1 Autoinducer compounds
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181765 Reacting an azide compound with an amine to form an intermediate, reducting the azide of the intermediate to form amine; amidation, reduction of azide, azidation, blocking hydroxy group, lactonization and deblocking
09/25/2003US20030181757 Liquid phase oxidation of halogenated ortho-xylenes
09/25/2003US20030181735 Catalyzing the oxidation of xylene, naphthalene over two different fixed-bed catalysts, process control, temperature control by heat exchanging
09/25/2003US20030181718 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
09/25/2003US20030181514 Therapeutic compounds and methods
09/25/2003US20030181506 Hetercyclic carboxy compounds such as alpha-methyl-2-naphthalene-methyl 2-(4-fluorophenoxy)-5-oxotetrahydrofuran-2-carboxylate used to selectively regulate induction of cytotoxic effecter macrophages
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003US20030181445 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders
09/25/2003US20030181319 Process for preparing nonracemic chiral alcohols
09/25/2003US20030181318 Process for preparing nonracemic chiral alcohols
09/25/2003US20030180804 (Serine) protease modulators; membrane proteins
09/25/2003US20030178295 Via cyanide exchange with cuprous cyanide as solvent; film distillation
09/25/2003CA2479481A1 Therapeutic ion channel blocking agents and methods of use thereof
09/25/2003CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/24/2003EP1346989A1 Improved process for the preparation of citalopram and its hydrobromide
09/24/2003EP1346988A1 Process for preparing optically active 2,3-dihydro- benzofuran compounds
09/24/2003EP1346987A1 Benzofuran derivatives and pharmaceutical compositions containing the same
09/24/2003EP1346972A1 Process for producing optically active halohydrin compound
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345919A2 Novel c-glycoside derivatives and use thereof
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0904270B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444564A Biphenyl carboxamides
09/24/2003CN1444554A Method for catalystically producing organic substances by partial oxidation
09/24/2003CN1443761A 2-aryl substitutled benzo[b] furan compound, its preparation method and application
09/24/2003CN1443756A Bicyclic aromatic compound
09/24/2003CN1121907C Coating catalyst for catalytic gaseous phase oxidation of aromatic hydrocarbons
09/24/2003CN1121901C Process for regeneration of carbon supported rhenium containing catalysts
09/24/2003CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate
09/23/2003US6624316 Bromination of 2-nitrovinylfuran using charcoal; one step; neutralization and dehydrobromination using pyridine dissolved in carbon disulfide; purification, crystallization
09/23/2003US6624315 Method of gas phase catalytic oxidation to give maleic acid anhydride
09/23/2003US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624177 Treating diseases in which matrix melatoproteinases are involved such as multiple sclerosis, atherosclerotic plaque rupture, restenosis, aortic aneurism, heart failure, periodontal disease, corneal ulceration, burns, decubital
09/23/2003US6624168 Bactericides, bacteriostats
09/23/2003CA2244196C Dihydrobenzofuran compounds useful as anti-inflammatory agents
09/23/2003CA2127110C Carbamates and crop protection agents containing them
09/23/2003CA2099537C Herbicide intermediate o-nitrophenyl cyclopropyl ketone and a method for the preparation thereof
09/18/2003WO2003076478A1 Arene-ruthenium complexes immobilized on polymers, catalysts consisting of the complexes, and processes for organic syntheses with the same
09/18/2003WO2003076443A1 Spiro compounds with npy antagonistic activity
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076422A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076395A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076388A2 Bis-aniline derivatives useful as potassium channels modulators
09/18/2003WO2003076072A1 Practical chiral zirconium catalyst
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075915A1 5-}2-hydroxy-3-`1-(3-trifluoromethylphenyl)-cyclopropyl!-propionylamino}- phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
09/18/2003WO2003075914A1 Citalopram for the treatment of elevated blood pressure
09/18/2003WO2003075907A2 Small molecule entry inhibitors
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2003011851A3 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002038557A9 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
09/18/2003US20030176717 Process for the preparation of aryloctanoyl amides
09/18/2003US20030176716 Oxidation of o-xylene in the presence of a catalyst; locating upstream of the separator a heat exchanger through which a cooling medium flows, and hot reaction gas being passed through exchanger for interaction with cooling medium